Haemorrhagic fevers

Haemorrhagic fever with renal syndrome

Title: Requirements for Haemorrhagic Fever with Renal Syndrome (HFRS) Vaccine (Inactivated); Adopted 1993, TRS No 848, Annex 2


  • WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WCC, Geneva, Switzerland, 27–28 April 2015
  • WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WCC, Geneva, Switzerland, 29–30 April 2015


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971